Recorded live Symposium at GMDI on April 27th, 2018.
Presenters: Prof. Anita MacDonald. PhD, BSc, OBE, Anne Daly, BSc Hons, MMed Sci, RD, Dr. Sandy Van Calcar PhD RD LD, and Dr. Joyanna Hansen, PhD, RD, LD
Emerging evidence of the use of glycomacropeptide (GMP) based products in the dietary management of PKU has generated interest in its potential benefits. Long-term efficacy studies and use in individuals under the age of 11 are lacking for the use of GMP. This presentation outlines the most recent data from an ongoing long-term clinical trial in the UK, involving children with PKU from the age of 5 years, taking a GMP based medical food as part of their dietary management. Additionally, the processes and challenges of initiating a US based GMP clinical trial, with ongoing recruitment, are discussed.
- Understand how an ongoing clinical research trial has shaped the nutritional formulation of a GMP based medical food
- Describe factors related to long-term growth, nutritional status and metabolic control of children taking a GMP based medical food compared to an amino acid based medical food
- Review the process for initiating a clinical trial using medical foods in a U.S. metabolic center
- Identify research resources that may be helpful for dietitians seeking to initiate a clinical trial of medical foods
This program is eligible for 1 CPEU for registered dietitians/nutritionists through the Commission on Dietetic Registration through April 27th, 2021.
Advances in the Nutritional Management of PKU: The Story Unfolds from Vitaflo USA on Vimeo.